Ligand validation:8DR9

NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE

NAD is a Ligand Of Interest in 8DR9 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8DR9_NAD_B_603	84%	41%	0.096	0.959	0.9	1.43	1	8	5	0	100%	1
8DR9_NAD_A_602	50%	58%	0.164	0.915	0.74	0.83	1	3	5	0	100%	0.2
2ONP_NAD_C_503	90%	16%	0.086	0.968	2.07	1.76	10	12	0	0	100%	1
1O01_NAD_F_5506	87%	19%	0.094	0.967	2.15	1.46	9	7	0	0	100%	1
1O04_NAD_C_6503	73%	27%	0.109	0.935	1.55	1.54	3	8	1	0	100%	1
1CW3_NAD_G_7502	71%	31%	0.128	0.95	1.44	1.43	5	8	4	0	100%	1
3N82_NAD_C_503	71%	32%	0.122	0.942	1.71	1.11	4	2	1	0	100%	1
4URF_NAD_A_1249	100%	45%	0.034	0.995	0.96	1.2	2	4	0	0	100%	1
2C5A_NAD_B_1374	100%	25%	0.039	0.992	1.34	1.84	6	7	1	0	100%	1
1HET_NAD_A_402	100%	11%	0.043	0.994	2.25	2.1	9	8	0	0	100%	0.9068
2JHF_NAD_B_403	100%	18%	0.04	0.99	2.08	1.62	11	5	2	0	100%	1
1HEU_NAD_B_402	100%	8%	0.043	0.993	2.5	2.41	13	11	0	0	100%	0.8886

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.